This could give enterprises access to a 3D, AI-accelerated future without requiring investment in costly GPU-scale ...

Cadence Design Systems unveiled on Wednesday a new supercomputer based on chips from Nvidia that will speed up its software ...

Check out these 10 classic games like 'The Legend of Zelda' and 'GTA: San Andreas' that every gamer must play for their ...

The graphics card driver plays a major role in system performance, which is why occasionally checking for updates is a good habit to adopt. This is especially important for gamers, as keeping the ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

His ousting of Peter Marks—a senior official at the Food and Drug Administration and key proponent of faster drug approvals—sent biotech stocks tumbling last month and stoked concerns that the ...

BUENOS AIRES--(BUSINESS WIRE)--GridX, Latin America's largest biotechnology investment fund and company builder, is set to begin its international Roadshow featuring 21 innovative startups across ...

As the world enters an age of biotechnology, there is emerging evidence that China is “distorting” biotechnology markets and is quickly ascending to “dominance” in this field, having made ...

A Soyuz capsule with 2 Russians and 1 American returns to Earth from the International Space Station 'American Pickers' star Mike Wolfe makes ‘tough decision’ to shutter Nashville store Three ...

One relatively small biotech company has made a breakthrough that could be used to treat a range of cancer. While it's been a poor performer for the past few years despite promising growth ...

Passed by the House in September 2024, the Biosecure Act took a particularly hardline stance on Chinese biotech, denying top firms access to U.S. pharma supply chains. The bill forced U.S ...

Shanghai-based VelaVigo has been busy. The biotech granted Avenzo Therapeutics ex-China rights to a Nectin4xTROP2 bispecific antibody-drug conjugate in November, netting up to $50 million in ...